Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Neurochemical correlates of the waltzing-shaker syndrome in the Varitint-waddler mouse

Abstract

In the order to examine activity of the dopamine system in the Varitint-waddler (Va) mouse, behavioral effects of haloperidol and dexamphetamine on waltzing Va, non-waltzing Va and non-mutant mice were investigated. The dopamine system of these mice was studied by macro-autoradiography with 14C-dihydroxyphenylalanine. High doses (5.0–10.0 μmol/kg) of haloperidol were similarly effective in both mutant and non-mutant mice: they induced a highly characteristic cataleptic effect in all types of mice. Low doses (0.10–3.16 μmol/kg) were significantly less effective in the waltzing Va mice: they induced a marked shift from a small increase of the sitting frequency in the waltzing mice to a large increase of this measure in the non-mutant mice. Several behavioral measures of the untreated waltzing mice mimicked those of control mice treated with amphetamine. Amphetamine reversed original strain differences and depressed several stereotyped Va activities. The autoradiograms of the waltzing Va mice, which showed a marked labelling of the Harderian gland, differed significantly from those of the nonwaltzing Va mice and controls, which showed no labelling of this gland. It is suggested that a hyperactive dopaminergic mechanism is involved in the waltzingshaker syndrome of the Varitint-waddler.

This is a preview of subscription content, log in to check access.

References

  1. Abeelen, J. H. F. van: Behavioural profiles of neurological mutant mice. Genetica 37, 149–158 (1966).

  2. Bartholini, G., Bates, H. M., Burkhard, W. P., Pletcher, A.: Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylaline after inhibition of peripheral decarboxylase. Nature (Lond.) 215, 852 (1967).

  3. Bloom, F. E., Costa, F., Salmoiraghi, G. C. J.: Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetyloholine, epinephrine and dopamine, administered by microelectrophoresis. J. Pharmacol. exp. Ther. 150, 244 (1965).

  4. Cloudman, A. M., Bunker, L. F., Jr.: The Varitint-waddler mouse. A dominant mutation in Mus musculus. J. Hered. 36, 259 (1945).

  5. Connor, J. D.: Caudate unit responses to nigral stimuli: evidence for a possible nigro-striatal pathway. Science 160, 899 (1968).

  6. Constantinides, J., Bartholini, G., Tissot, R., Pletcher, A.: Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of the brain. Experientia (Basel) 21, 130 (1968).

  7. Cools, A. R.: The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour. Arch. int. Pharmacodyn. (in press) (1971).

  8. -Asymmetry in fur pattern and laterality in circling behaviour in the Varitintwaddler (Va) mouse. (In press) (1971).

  9. —, Rossum, J. M. van: Caudal dopamine and stereotype behaviour of cats. Arch. int. Pharmacodyn. 187, 136 (1970).

  10. Costall, B., Olley, J. E.: Cholinergic and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen. Neuropharmacology 10, 297 (1971).

  11. Deol, M. S.: The anomalies of the labyrinth of the mutants Varitint-waddler, shaker-2 and Yerker in the mouse. J. Genet. 42, 562 (1954).

  12. Dobzansky, T.: Principles of genetics, p. 130. Eds. E. W. Sinnott, L. C. Dunn, and T. Dobzansky. New York: Mc Graw-Hill 1958.

  13. Erway, L., Hurley, L. S., Fraser, A.: Neurological defect: Manganese in phenocopy and prevention of a genetic abnormality of inner ear. Science 152, 1766 (1966).

  14. Florio, V., Longo, V. G.: Neuroleptic drugs and the central dopaminergic system. Neuropharmacology 10, 45 (1971).

  15. Fog, R.: Role of the corpus striatum in typical behavioral effects in rats, produced by both amphetamine and neuroleptic drugs. Acta pharmacol. (Kbh.) 25, suppl. 4, 59 (1967b).

  16. Fog, R., Randrup, A., Pakkenberg, H.: Aminergic mechanism in corpus striatum and amphetamine-induced stereotyped behaviour. Psychopharmacologia (Berl.) 11, 179 (1967a).

  17. — — —: Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats. Psychopharmacologia (Berl.) 12, 428 (1968).

  18. — — —: Destruction in corpus striatum and cortex in cat brains and the effects on pharmacologically-induced stereotyped aggressive and cataleptic behaviour. Psychopharmacologia (Berl.) 18, 346 (1970).

  19. Fuxe, K., Ungerstedt, U.: Histochemical, biochemical and functional studies on cerebral monoamines neurons after acute and chronic amphetamine administration. In: Amphetamines and related compounds, p. 257. Eds. E. Costa and S. Garattini. New York: Raven Press 1970.

  20. Herz, A., Zieglgänsberger, W.: Synaptic excitation in the corpus striatum inhibited by microelectrophoretically administered dopamine. Experientia (Basel) 22, 839 (1966).

  21. Hornykiewicz, O. J.: Dopamine (3′-hydroxytyramine) and brain dysfunction. Pharmacol. Rev. 18, 925 (1966).

  22. Klawan, H. L.: A pharmacologic analysis of Huntington's chorea. Europ. Neurol. 4, 148 (1970).

  23. Lasagna, L., Epstein, L. C.: The use of amphetamine in the treatment of hyperkinetic children. In: Amphetamines and related compounds, p. 849. Eds. E. Costa and S. Garattini. New York: Raven Press 1970.

  24. McKenzie, G. M., Szerb, J. C.: The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus. J. Pharmacol. exp. Ther. 162, 32 (1968).

  25. Proctor, P.: Psychosis, Dyskinesia and Hyperpigmentation. Lancet 1971, 1069.

  26. Randrup, A., Munkvad, I.: Behavioural stereotypes induced by pharmacological agents. Pharmacopsychiat. 1, 18 (1968).

  27. — —: Biochemical, anatomical and, psychological investigations of stereotyped behaviour induced by amphetamine. In: Amphetamines and related compounds, p. 695. Eds. E. Costa and S. Garattini. New York: Raven Press 1970.

  28. —, Scheel-Krüger, J.: Diethyldithiocarbamate and amphetamine stereotyped behaviour. J. Pharm. Pharmacol. 18, 752 (1966).

  29. Searle, A. G.: Comparative genetics of coat colour in mammals, p. 45. London: Logos Press 1968.

  30. Siegel, S.: Nonparametric statistics for the behavioural Sciences. New York: McGraw Hill 1956.

  31. Ullberg, S.: Studies on the distribution and fate of 35S-labelled benzylpenicillin in the body. Acta radiol. (Stockh.) Suppl. 118, 1 (1954).

  32. Wetterberg, L., Yuwiler, A., Ulrich, R., Geller, E., Wallace, R.: Harderian gland: influence on pineal hydroxyindol-O-methyltransferase activity in neonatal rats. Science 170, 194 (1970).

  33. York, D. H.: The inhibitory action of dopamine on neurons of the caudate nucleus. Brain Res. 5, 263 (1967).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cools, A.R. Neurochemical correlates of the waltzing-shaker syndrome in the Varitint-waddler mouse. Psychopharmacologia 24, 384–396 (1972). https://doi.org/10.1007/BF00402533

Download citation

Key words

  • Waltzing-Shaker Syndrome
  • Amphetamine
  • Haloperidol
  • Mice